As of 2025-03-19, the Relative Valuation of Pliant Therapeutics Inc (PLRX) is (70.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.69 USD, the upside of Pliant Therapeutics Inc based on Relative Valuation is -4296.1%.
The range of the Relative Valuation is (71.70) - (73.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 24.7x | 22.4x |
| Forward P/E multiples | 18.7x - 21.3x | 18.9x |
| Fair Price | (71.70) - (73.28) | (70.91) |
| Upside | -4342.8% - -4436.3% | -4296.1% |
| Date | P/E |
| 2025-03-18 | -0.49 |
| 2025-03-17 | -0.50 |
| 2025-03-14 | -0.45 |
| 2025-03-13 | -0.44 |
| 2025-03-12 | -0.46 |
| 2025-03-11 | -0.46 |
| 2025-03-10 | -0.42 |
| 2025-03-07 | -0.47 |
| 2025-03-06 | -0.46 |
| 2025-03-05 | -0.44 |
| 2025-03-04 | -0.39 |
| 2025-03-03 | -0.40 |
| 2025-02-28 | -1.00 |
| 2025-02-27 | -0.95 |
| 2025-02-26 | -0.91 |
| 2025-02-25 | -0.92 |
| 2025-02-24 | -0.88 |
| 2025-02-21 | -0.90 |
| 2025-02-20 | -0.88 |
| 2025-02-19 | -0.87 |
| 2025-02-18 | -0.87 |
| 2025-02-14 | -0.89 |
| 2025-02-13 | -0.96 |
| 2025-02-12 | -0.79 |
| 2025-02-11 | -0.76 |
| 2025-02-10 | -0.89 |
| 2025-02-07 | -2.27 |
| 2025-02-06 | -3.48 |
| 2025-02-05 | -3.65 |
| 2025-02-04 | -3.31 |
| 2025-02-03 | -3.26 |
| 2025-01-31 | -3.13 |
| 2025-01-30 | -3.10 |
| 2025-01-29 | -3.13 |
| 2025-01-28 | -3.18 |
| 2025-01-27 | -3.20 |
| 2025-01-24 | -3.18 |
| 2025-01-23 | -3.24 |
| 2025-01-22 | -3.18 |
| 2025-01-21 | -3.22 |
| 2025-01-17 | -3.26 |
| 2025-01-16 | -3.38 |
| 2025-01-15 | -3.68 |
| 2025-01-14 | -3.27 |
| 2025-01-13 | -3.43 |
| 2025-01-10 | -3.50 |
| 2025-01-08 | -3.67 |
| 2025-01-07 | -3.86 |
| 2025-01-06 | -3.84 |
| 2025-01-03 | -3.94 |